Worth reading
61In focus
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
12200
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of stock acquisition rights for stock-based compensation stock options
Who receives how much
Up to 12,200 common shares (122 stock acquisition rights, 100 shares per right)
3 directors, up to 122 rights in total (breakdown by recipient not disclosed)
The lower thin line represents the existing number of shares to which these shares will be added.
Accounting fair value on the grant date (per stock acquisition right; amount not disclosed)
Amount of funds to be raised
Total amount to be paid: ¥0; estimated net proceeds: ¥0
Total Stock-Based Compensation
Director compensation equivalent to the accounting fair value on the grant date. Amount not disclosed.
Terms of the stock acquisition rights
Exercise price
¥1 per share. No adjustment provisions.
Exercise period
From 30 June 2027 to 29 June 2042
Number of Stock Acquisition Rights
Total number issued: up to 122 rights; unexercised balance: Not disclosed
Reason for acquisition without consideration
Expiration of the exercise period or 5 years after retirement; a material violation of laws, regulations or internal rules; conviction resulting in imprisonment or a more severe penalty; appointment to a competing company without permission; the death of a successor to the rights; an offer to surrender all rights; or a resolution by the Board of Directors to acquire all or part of the rights.
Conditions on transfer restrictions
Restricted stock is stock awarded as compensation that cannot be sold during a specified period, with the restrictions lifted once the applicable conditions are met.
Transfer restriction period
The transfer restriction period is not specified as a number of years and continues for the period during which the stock acquisition rights are held by the rights holder or successor to the rights.
Conditions for lifting transfer restrictions
There are no conditions for lifting the transfer restriction, and the rights holder or successor to the rights may not transfer or pledge the stock acquisition rights. Exercise generally requires the holder to remain a director or corporate auditor, and is permitted only within 5 years after retirement.
Categories and Number of Persons Covered
3 directors of the company, up to 122 rights (100 shares per right)
Intended allottee's holding policy
Transfer and pledging of the stock acquisition rights are prohibited. The rights may be exercised subject to conditions including exercise within 5 years after retirement.
Basis for determining the amount to be paid
The issue price of the stock acquisition rights is their accounting fair value on the grant date. The reference closing price and average share price, and the discount and premium rates, were not disclosed.
Procedures under the Corporate Code of Conduct
The disclosure states that the recipients are those elected as directors of the company at the general meeting of shareholders held on 22 May 2026. Whether an independent third-party opinion was obtained was not disclosed.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of stock acquisition rights for stock-based compensation stock options |
| Number of shares to be issued or disposed of | Up to 12,200 common shares (122 stock acquisition rights, 100 shares per right) |
| Issue price and disposal price | Accounting fair value on the grant date (per stock acquisition right; amount not disclosed) |
| Amount of funds to be raised | Total amount to be paid: ¥0; estimated net proceeds: ¥0 |
| Intended allottee | 3 directors, up to 122 rights in total (breakdown by recipient not disclosed) |
| Intended allottee's holding policy | Transfer and pledging of the stock acquisition rights are prohibited. The rights may be exercised subject to conditions including exercise within 5 years after retirement. |
| Basis for determining the amount to be paid | The issue price of the stock acquisition rights is their accounting fair value on the grant date. The reference closing price and average share price, and the discount and premium rates, were not disclosed. |
| Exercise price | ¥1 per share. No adjustment provisions. |
| Exercise period | From 30 June 2027 to 29 June 2042 |
| Number of Stock Acquisition Rights | Total number issued: up to 122 rights; unexercised balance: Not disclosed |
| Transfer restriction period | The transfer restriction period is not specified as a number of years and continues for the period during which the stock acquisition rights are held by the rights holder or successor to the rights. |
| Conditions for lifting transfer restrictions | There are no conditions for lifting the transfer restriction, and the rights holder or successor to the rights may not transfer or pledge the stock acquisition rights. Exercise generally requires the holder to remain a director or corporate auditor, and is permitted only within 5 years after retirement. |
| Reason for acquisition without consideration | Expiration of the exercise period or 5 years after retirement; a material violation of laws, regulations or internal rules; conviction resulting in imprisonment or a more severe penalty; appointment to a competing company without permission; the death of a successor to the rights; an offer to surrender all rights; or a resolution by the Board of Directors to acquire all or part of the rights. |
| Categories and Number of Persons Covered | 3 directors of the company, up to 122 rights (100 shares per right) |
| Total Stock-Based Compensation | Director compensation equivalent to the accounting fair value on the grant date. Amount not disclosed. |
| Procedures under the Corporate Code of Conduct | The disclosure states that the recipients are those elected as directors of the company at the general meeting of shareholders held on 22 May 2026. Whether an independent third-party opinion was obtained was not disclosed. |
Items this document does not state (12)
Total issue valueEstimated issuance expensesSpecific use of fundsPayment dateDilution RateTotal number of issued sharesUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To strengthen the alignment between directors’ compensation and the company’s performance and share value, and to increase their motivation and morale to improve performance and enhance corporate value over the medium to long term by sharing with shareholders not only the benefits of a rising share price but also the risks of a decline.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.